Browse Conditions Browse Medicines

NICE guidance - Lung cancer: diagnosis and management

For Lung cancer (Non-Small Cell)

The National Institute for Health and Care Excellence (NICE) have published an updated their guideline on the diagnosis and management of lung cancer.

The guideline aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up.

The guidelines are intended to inform:
  • People with lung cancer and their families and carers
  • Healthcare professionals
  • Commissioners and providers
NICE have reviewed the evidence and made new recommendations on:
  • intrathoracic lymph node assessment
  • brain imaging for people with non-small-cell lung cancer
  • radical radiotherapy (including stereotactic ablative radiotherapy [SABR]) for people with non-small-cell lung cancer
  • chemoradiotherapy and surgery for people with stage IIIA-N2 non-small-cell lung cancer
  • thoracic radiotherapy and prophylactic cranial irradiation for people with small-cell lung cancer
This guideline (NG122) updates and replaces NICE guideline CG121 (April 2011).

Lung cancer: the care you should expect
Lung cancer is one of the most common types of cancer, with over 46,000 people diagnosed in 2015. It causes symptoms like a persistent cough, coughing up blood, and feeling short of breath. People may not get symptoms in the early stages, and because of this lung cancer is often diagnosed late. In recent years, better tests and treatments are starting to make a difference and can mean a better outlook for many people.

We want this guideline to make a difference to people with lung cancer by making sure:
  • doctors know the best ways to diagnose lung cancer quickly and accurately
  • you’re offered the right tests and scans to get the best information about the type and stage of cancer – this will help in planning your treatment
  • your care team explains the treatments, or combinations of treatments, that are likely to work best and help you decide what’s right for you.
Making decisions together
Decisions about treatment and care are best when they are made together. Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns.

To help you make decisions, think about:
  • What matters most to you – what do you want to get out of any treatment?
  • What are you most worried about – are there risks or downsides to the treatment that worry you more than others?
  • How will the treatment affect your day-to-day life?
  • What happens if you don’t want to have treatment?
If you can’t understand the information you are given, tell your healthcare professional

© NICE [2019]

Lung cancer: diagnosis and management. NICE guideline [NG122] Published date: March 2019
Available from: See Link below. All rights reserved. Subject to Notice of rights
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

The information provided by NICE was accurate at the time this article was issued.


NICE guidance - Lung cancer: diagnosis and management

Reporting of suspected adverse reactions

Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.


Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.


About condition